Economy
Finance, markets, investments, cryptocurrency and economic news
Alibaba-backed AI startup MiniMax successfully raised $618M in its Hong Kong IPO, with shares more than doubling on the first day. Discover the details of MiniMax Hong Kong IPO success.
The A7A5 ruble-linked stablecoin has outgrown USDT and USDC over the past 12 months. Explore how this asset is bypassing sanctions to become a top performer.
SGX is proposing a 'Global Listing Board' to enable dual IPOs with Nasdaq by 2026. Learn about the $1.55 billion requirement and the adoption of U.S. disclosure rules.
PRISM by Liabooks
Place your ad in this space
[email protected]Discover how Linea and ether.fi are maximizing Ethereum staking yield through a new institutional strategy involving restaking and qualified custodians.
KOSPI hits a fresh record high of 4,586.32 on Jan 9, 2026, driven by defense and auto stocks. Discover the market trends and sector outlook for the 4600 milestone.
A three-day streak of Bitcoin ETF outflows has wiped out all gains made in early January. Market sentiment shifts as institutional investors pull back.
LG Energy Solution reported a narrowed Q4 2025 operating loss of 122 billion won. While EV demand remains weak, a pivot to ESS and AMPC tax credits are cushioning the blow.
PRISM by Liabooks
Place your ad in this space
[email protected]A two-step liquidation reset has trapped the price between $2.07 support and $2.17 resistance. Explore the market impact and trader sentiment in our latest update.
The Zcash protocol remains stable despite the 2026 governance clash and Bootstrap restructuring. Analyze the impact on ZEC network security and investment risks.
An attacker exploited a legacy TrueFi TRU smart contract, buying tokens for $0 and extracting Ether. This highlights the severe risks of technical debt in DeFi protocols.
On Jan. 9, 2026, the KOSPI hit a record high of 4,565.88, driven by strong gains in defense and shipbuilding stocks like Hanwha Aerospace and HD Hyundai Heavy Industries.
PRISM by Liabooks
Place your ad in this space
[email protected]Aktis Oncology successfully prices its upsized US IPO at $18 per share. Explore the implications of this radiopharmaceutical biotech debut in 2026.